Outset Medical: Revising To Buy, Market Dynamics, Guidance As Catalysts (Upgrade)

Dec. 06, 2022 3:23 PM ETOutset Medical, Inc. (OM) StockOM
Zach Bristow
4.17K Followers

Summary

  • Outset Medical, Inc. revised FY22 guidance to the upside, with management forecasts now ahead of consensus.
  • Home hemodialysis market is poised for ongoing growth into 2028.
  • Outset Medical had robust quarter of growth at the top line in Q3.
  • Revising investment thesis for Outset Medical, Inc. to buy, price objectives $26 then $35.

Extracorporeal membrane oxygenation (ECMO)

Pijitra Phomkham/iStock via Getty Images

Investment Summary

Following our last 2 publications on Outset Medical, Inc. (NASDAQ:OM), where we rated the stock a firm hold, the clouds of investment return have since swelled and started to rain. OM caught

This article was written by

4.17K Followers
Equity strategist (US Equities)Technical focus on fundamental value drivers of business economics to uncover high probability long-term compounders. Seeking to buy at appropriate prices relative to intrinsic worth. Partners are represented over the cross-section of financial markets, from speculators, hedgers, long-term traders and the public. Research covers investment securities and futures & options markets. Shoot me a message to talk trade ideas or portfolio construction. Disclaimer:All research is strictly for informational purposes only. Not to be considered investment advice. Conduct your own due diligence. The Company accepts no responsibility for personal decisions made. Opinions of The Company and its affiliates may change from time to time without prior acknowledgement. The Company and its representatives share no economic relationship with any entities in which it holds common stock investments.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of OM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About OM Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on OM

Related Stocks

SymbolLast Price% Chg
OM
--